Transce3nd, LLC Ark Genomic Revolution ETF (De Transaction History
Transce3nd, LLC
- $237 Billion
- Q2 2025
A detailed history of Transce3nd, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Transce3nd, LLC holds 528 shares of ARKG stock, worth $16,436. This represents 0.01% of its overall portfolio holdings.
Number of Shares
528
Previous 540
2.22%
Holding current value
$16,436
Previous $11.2 Million
14.69%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ARKG
# of Institutions
283Shares Held
19MCall Options Held
3.93MPut Options Held
4.4M-
Jpmorgan Chase & CO New York, NY3.43MShares$107 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY3.18MShares$99.1 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.13MShares$66.2 Million0.0% of portfolio
-
Ubs Group Ag1.35MShares$42.1 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA1.09MShares$33.8 Million0.01% of portfolio